📊 INMD Key Takeaways
Is InMode Ltd. (INMD) a Good Investment?
Unable to conduct fundamental analysis due to complete absence of financial data. All income statement, balance sheet, cash flow, and profitability metrics are unavailable, preventing any meaningful assessment of the company's financial health, profitability trends, or growth quality.
InMode remains fundamentally strong on balance sheet quality, with $302.5 million of cash, $83.6 million of marketable securities, $169.2 million of short-term deposits, no bank debt, and continued positive free cash flow. The core issue is operating deterioration: revenue has declined for two straight years, gross margin has compressed, and operating income fell materially from 2023 levels, indicating weaker demand and lower earnings quality than the headline cash position suggests. The company is still highly profitable, but the current fundamental picture is best described as financially resilient rather than clearly reaccelerating.
Why Buy InMode Ltd. Stock? INMD Key Strengths
- Company operates in medical device sector (electromedical apparatus) which has structural growth drivers
- Listed on Nasdaq suggesting meets exchange listing standards
- Zero insider selling activity in last 90 days suggests management confidence
- Very strong net-cash balance sheet with minimal leverage and liabilities far below liquid assets
- Still generates high profitability, including roughly 78.5% gross margin and 23.0% operating margin in 2025
- Free cash flow remains solid because the business is capital-light, with about $1.0 million of capital expenditures in 2025
INMD Stock Risks: InMode Ltd. Investment Risks
- No financial data available - unable to assess revenue trends, profitability, or cash generation
- Cannot evaluate balance sheet strength, liquidity position, or leverage levels
- Lack of operating metrics prevents assessment of business fundamentals and operational efficiency
- Revenue declined from $492.0 million in 2023 to $394.8 million in 2024 to $370.5 million in 2025, showing sustained top-line pressure
- Margin compression is ongoing, with gross margin falling from about 83.6% in 2023 to 80.3% in 2024 to 78.5% in 2025
- Operating cash flow weakened to $85.3 million in 2025 from $132.7 million in 2024 and $176.8 million in 2023, while inventory rose materially
Key Metrics to Watch
- Revenue growth and gross margin trends when data becomes available
- Operating cash flow and free cash flow generation
- Balance sheet composition including debt levels and cash position
- Revenue growth by geography and consumables mix to confirm whether demand stabilizes
- Operating margin and operating cash flow conversion, especially alongside inventory and receivables trends
InMode Ltd. (INMD) Financial Metrics & Key Ratios
💡 AI Analyst Insight
The current ratio below 1.0x warrants monitoring of short-term liquidity.
INMD Profit Margin, ROE & Profitability Analysis
INMD vs Healthcare Sector: How InMode Ltd. Compares
How InMode Ltd. compares to Healthcare sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is InMode Ltd. Stock Overvalued? INMD Valuation Analysis 2026
Based on fundamental analysis, InMode Ltd. has mixed fundamental signals relative to the Healthcare sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
InMode Ltd. Balance Sheet: INMD Debt, Cash & Liquidity
INMD Revenue Growth, EPS Growth & YoY Performance
INMD SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for InMode Ltd. (CIK: 0001742692)
📋 Recent SEC Filings
❓ Frequently Asked Questions about INMD
What is the AI rating for INMD?
InMode Ltd. (INMD) has a Combined AI Rating of HOLD from Claude (HOLD) and ChatGPT (HOLD) with 42% combined confidence, based on fundamental analysis of SEC EDGAR filings.
What are INMD's key strengths?
Claude: Company operates in medical device sector (electromedical apparatus) which has structural growth drivers. Listed on Nasdaq suggesting meets exchange listing standards. ChatGPT: Very strong net-cash balance sheet with minimal leverage and liabilities far below liquid assets. Still generates high profitability, including roughly 78.5% gross margin and 23.0% operating margin in 2025.
What are the risks of investing in INMD?
Claude: No financial data available - unable to assess revenue trends, profitability, or cash generation. Cannot evaluate balance sheet strength, liquidity position, or leverage levels. ChatGPT: Revenue declined from $492.0 million in 2023 to $394.8 million in 2024 to $370.5 million in 2025, showing sustained top-line pressure. Margin compression is ongoing, with gross margin falling from about 83.6% in 2023 to 80.3% in 2024 to 78.5% in 2025.
What is INMD's revenue and growth?
InMode Ltd. reported revenue of N/A.
Does INMD pay dividends?
InMode Ltd. does not currently pay dividends.
Where can I find INMD SEC filings?
Official SEC filings for InMode Ltd. (CIK: 0001742692) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is INMD's EPS?
InMode Ltd. has a diluted EPS of $0.00.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.
Is INMD a good stock to buy right now?
Based on our AI fundamental analysis in April 2026, InMode Ltd. has a HOLD rating with 42% confidence. Review the strengths and risks sections above before making a decision. This is not investment advice.
Is INMD stock overvalued or undervalued?
Valuation metrics for INMD: ROE of N/A (sector avg: 15%), net margin of N/A (sector avg: 12%). Compare these metrics with sector averages to assess valuation.
Should I buy INMD stock in 2026?
Our dual AI analysis gives InMode Ltd. a combined HOLD rating for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is INMD's free cash flow?
InMode Ltd.'s operating cash flow is N/A, with capital expenditures of N/A.
How does INMD compare to other Healthcare stocks?
Vs Healthcare sector averages: Net margin N/A (avg: 12%), ROE N/A (avg: 15%), current ratio N/A (avg: 2).